Some notes - Diagnostics

•  Roche has revenue of ~USD 70 billion, mainly from pharma and 30% through diagnostics. (USD 15.7 billion). Diagnostics include molecular diagnostics, tissue d, diabetes care, professional lab solutions
• It is the largest player thus in dianostics space which is a USD 85 billion market size.  (estimated to reach 147 billion in 10 years). 
• Some estimates say 108 billion curren
• Broader testing market is USD 203 billion
• Instruments account for the highest portion
• Overall market growth limited - but India outpaces market significantly.
• Diagnostics space implies tools, tech and services that detect monitor and manage diseases.

"The diagnostics value chain spans instrument manufacturers, reagent suppliers, lab service providers (institutional and ambulatory), and point-of-care or at-home testing services. Automated platforms and LDTs (laboratory-developed tests) are key components, offering flexibility and innovation under specific regulatory regimes."

Company	Period	Diagnostics Segment Revenue
Quest Diagnostics	Q1 2025	$2.589 billion (diagnostics only)
	Full Year 2024	~$9.9 billion (overall, incl. diagnostics)
Qiagen	Q2 2025	Diagnostics +11% growth; no figure given
	Full Year 2024	$1.978 billion (total revenue)
Roche	Full Year 2024	~CHF 18.7 billion (~US $20 billion+)
Abbott	Full Year 2024	$9.34 billion (diagnostics)
	Q2 2025	$2.28 billion (diagnostics)
Siemens Healthineers	Full Year 2024	€4.42 billion (diagnostics)
	Q3 2025	~4% decline in diagnostics sales